ANA positivity was seen significantly more often present in the SRP group compared to the PRP group; 66.7% of the SRP patients and 14.1% of the PRP patients showed ANA positivity (p < 0.001). The gene discussed is BTG3; the disease is familial pityriasis rubra pilaris.